What changed: Gallbladder cancer
Every dated change on the records linked to Gallbladder cancer, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Trial result4Guideline1Milestone6This record1
September 2026 · 1
2024 · 1
2023 · 2
2022 · 2
2019 · 2
- 2019GuidelineGallbladder cancerGuideline BILCAP (Lancet Oncol 2019); ASCO adjuvant biliary guideline 2019: After resection
Adjuvant capecitabine for six months (BILCAP; ASCO guideline 2019); chemoradiation considered for positive margins or node-positive disease. (NCCN Category 1 (capecitabine))
- 2019MilestoneBILCAPBILCAP: adjuvant capecitabine
Six months of capecitabine after resection of biliary tract cancer becomes the adjuvant standard.